166 related articles for article (PubMed ID: 23124354)
1. Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy.
Catalano S; Panza S; Malivindi R; Giordano C; Barone I; Bossi G; Lanzino M; Sirianni R; Mauro L; Sisci D; Bonofiglio D; Andò S
Int J Cancer; 2013 May; 132(10):2237-47. PubMed ID: 23124354
[TBL] [Abstract][Full Text] [Related]
2. Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells.
Catalano S; Malivindi R; Giordano C; Gu G; Panza S; Bonofiglio D; Lanzino M; Sisci D; Panno ML; Andò S
J Biol Chem; 2010 Feb; 285(8):5581-93. PubMed ID: 20026603
[TBL] [Abstract][Full Text] [Related]
3. FXR induces SOCS3 and suppresses hepatocellular carcinoma.
Guo F; Xu Z; Zhang Y; Jiang P; Huang G; Chen S; Lyu X; Zheng P; Zhao X; Zeng Y; Wang S; He F
Oncotarget; 2015 Oct; 6(33):34606-16. PubMed ID: 26416445
[TBL] [Abstract][Full Text] [Related]
4. Androgens inhibit aromatase expression through DAX-1: insights into the molecular link between hormone balance and Leydig cancer development.
Maris P; Campana A; Barone I; Giordano C; Morelli C; Malivindi R; Sisci D; Aquila S; Rago V; Bonofiglio D; Catalano S; Lanzino M; Andò S
Endocrinology; 2015 Apr; 156(4):1251-62. PubMed ID: 25603045
[TBL] [Abstract][Full Text] [Related]
5. Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression.
Giordano C; Catalano S; Panza S; Vizza D; Barone I; Bonofiglio D; Gelsomino L; Rizza P; Fuqua SA; Andò S
Oncogene; 2011 Sep; 30(39):4129-40. PubMed ID: 21499302
[TBL] [Abstract][Full Text] [Related]
6. Histamine H4 receptor as a novel therapeutic target for the treatment of Leydig-cell tumours in prepubertal boys.
Abiuso AMB; Varela ML; Haro Durand L; Besio Moreno M; Marcos A; Ponzio R; Rivarola MA; Belgorosky A; Pignataro OP; Berensztein E; Mondillo C
Eur J Cancer; 2018 Mar; 91():125-135. PubMed ID: 29367056
[TBL] [Abstract][Full Text] [Related]
7. Farnesoid X Receptor Agonist GW4064 Inhibits Aromatase and ERβ Expression in Human Endometriotic Stromal Cells.
Wu PL; Zeng C; Zhou YF; Yin L; Yu XL; Xue Q
Reprod Sci; 2019 Aug; 26(8):1111-1120. PubMed ID: 30428773
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation.
Sirianni R; Chimento A; Malivindi R; Mazzitelli I; Andò S; Pezzi V
Cancer Res; 2007 Sep; 67(17):8368-77. PubMed ID: 17804753
[TBL] [Abstract][Full Text] [Related]
9. Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy.
Giordano C; Barone I; Vircillo V; Panza S; Malivindi R; Gelsomino L; Pellegrino M; Rago V; Mauro L; Lanzino M; Panno ML; Bonofiglio D; Catalano S; Andò S
Sci Rep; 2016 Feb; 6():21782. PubMed ID: 26899873
[TBL] [Abstract][Full Text] [Related]
10. Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cells.
Chimento A; Casaburi I; Bartucci M; Patrizii M; Dattilo R; Avena P; Andò S; Pezzi V; Sirianni R
Cell Death Dis; 2013 Aug; 4(8):e747. PubMed ID: 23907461
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid Receptor as a Potential Target to Decrease Aromatase Expression and Inhibit Leydig Tumor Growth.
Panza S; Malivindi R; Chemi F; Rago V; Giordano C; Barone I; Bonofiglio D; Gelsomino L; Giordano F; Andò S; Catalano S
Am J Pathol; 2016 May; 186(5):1328-39. PubMed ID: 26968343
[TBL] [Abstract][Full Text] [Related]
12. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
13. FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model.
Deuschle U; Schüler J; Schulz A; Schlüter T; Kinzel O; Abel U; Kremoser C
PLoS One; 2012; 7(10):e43044. PubMed ID: 23056173
[TBL] [Abstract][Full Text] [Related]
14. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
Noh K; Kim YM; Kim YW; Kim SG
Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
[TBL] [Abstract][Full Text] [Related]
15. Farnesoid X receptor antagonizes JNK signaling pathway in liver carcinogenesis by activating SOD3.
Wang YD; Chen WD; Li C; Guo C; Li Y; Qi H; Shen H; Kong J; Long X; Yuan F; Wang X; Huang W
Mol Endocrinol; 2015 Feb; 29(2):322-31. PubMed ID: 25496033
[TBL] [Abstract][Full Text] [Related]
16. Activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds.
Vaquero J; Briz O; Herraez E; Muntané J; Marin JJ
Biochim Biophys Acta; 2013 Oct; 1833(10):2212-9. PubMed ID: 23680185
[TBL] [Abstract][Full Text] [Related]
17. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
18. FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation.
Yao J; Zhou CS; Ma X; Fu BQ; Tao LS; Chen M; Xu YP
World J Gastroenterol; 2014 Oct; 20(39):14430-41. PubMed ID: 25339829
[TBL] [Abstract][Full Text] [Related]
19. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional Regulation of Human UDP-Glucuronosyltransferase 2B10 by Farnesoid X Receptor in Human Hepatoma HepG2 Cells.
Lu D; Wang S; Xie Q; Guo L; Wu B
Mol Pharm; 2017 Sep; 14(9):2899-2907. PubMed ID: 28267333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]